A detailed history of Guyasuta Investment Advisors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 9,686 shares of NVO stock, worth $846,265. This represents 0.08% of its overall portfolio holdings.

Number of Shares
9,686
Previous 13,050 25.78%
Holding current value
$846,265
Previous $1.86 Million 38.08%
% of portfolio
0.08%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $400,551 - $489,192
-3,364 Reduced 25.78%
9,686 $1.15 Million
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $593,383 - $1.3 Million
6,525 Added 100.0%
13,050 $1.19 Million
Q1 2023

Apr 28, 2023

SELL
$132.34 - $159.14 $95,946 - $115,376
-725 Reduced 10.0%
6,525 $1.04 Million
Q2 2017

Aug 09, 2017

BUY
N/A
7,250
7,250 $311,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Guyasuta Investment Advisors Inc Portfolio

Follow Guyasuta Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.